Olivia C. Ware

Insider Reports History

Identity Who this page is about. 1 identity field
Location
Los Angeles, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Owner filing signature
/s/ Michelle Gilson, as Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Olivia C. Ware

Form 4 holding Director

Revance Therapeutics, Inc.

Security class
Stock Option (Right to buy)
Shares / value
23,458
Estimated value
Report date
01 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Arcellx, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
28 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Olivia C. Ware

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .